Antiplatelet therapy within 30 days of percutaneous coronary intervention with stent implantation

Med J Aust. 2020 Aug;213(3):124-125. doi: 10.5694/mja2.50507. Epub 2020 Feb 17.

Authors

Benjumin Hsu¹, Michael O Falster¹, Andrea L Schaffer¹, Sallie Pearson^{1

2}, Louisa Jorm¹, David B Brieger³

Affiliations

¹ Centre for Big Data Research in Health, UNSW Australia, Sydney, NSW.
² Menzies Centre for Health Policy, University of Sydney, Sydney, NSW.
³ Concord Repatriation General Hospital, Sydney, NSW.

PMID: 32067236
DOI: 10.5694/mja2.50507

No abstract available

Keywords: Coronary disease; Pharmacoepidemiology; Population health; Preventive medicine.

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Australia
Costs and Cost Analysis
Female
Humans
Insurance Benefits / statistics & numerical data*
Logistic Models
Male
Middle Aged
Percutaneous Coronary Intervention / methods*
Platelet Aggregation Inhibitors / therapeutic use*
Stents*
Time Factors
Young Adult

Substances

Platelet Aggregation Inhibitors